Healthcare
Live Price
Offline$9.65
-2.53% today
1Y Change
-38.92%
Window
Jun 20, 2025 → Jun 18, 2026
Coverage: 250 bars · Jun 20, 2025 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
ARS Pharmaceuticals, Inc. (SPRY) is a Healthcare stock with a market cap of $850.00M and listed on NASDAQ. The stock last traded around $9.65 and down 38.9% across the available one-year price window (Jun 20, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of -5.5%, EPS growth of -2209.1%, a dividend yield of 0.0%. What stands out right now is revenue -5.5%, EPS -2209.1%, free cash flow -1418.5% with operating margin -212.9% and ROIC -62.0%. Valuation already assumes a fairly strong business story at price/sales 10.1. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SPRY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SPRY
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SPRY Max Drawdown
-63.32%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SPRY and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.